The TECPR2 protein functions within a complex cellular environment, where its activity is potentially influenced by various signaling pathways. Compounds that raise intracellular levels of second messengers like cAMP can activate kinases such as PKA, which in turn may phosphorylate downstream proteins that interact with TECPR2, potentially leading to its functional activation. Similarly, those that increase intracellular calcium might activate calcium-dependent kinases and other proteins that can interact with or cause post-translational modifications of TECPR2, thereby influencing its activity. Additionally, compounds that inhibit specific phosphatases can lead to a sustained phosphorylation state within the cell, which may affect TECPR2 activity through altered protein-protein interactions or other regulatory mechanisms.
Moreover, the modulation of lipid signaling pathways by altering the activity of enzymes such as phospholipase C or PI3K can lead to changes in downstream effectors, possibly impacting the function of TECPR2. For instance, the inhibition of PI3K can result in attenuated AKT signaling, which may have repercussions for proteins that are functionally connected to this pathway, including TECPR2. Furthermore, the inhibition of kinases such as CaMKII or MEK1 can cause shifts in the cellular phosphorylation landscape, which can indirectly lead to the activation of TECPR2 through a complex web of signaling interactions and feedback mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP and cGMP by preventing their degradation, potentially enhancing PKA and PKG pathways that might intersect with TECPR2 functions. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium levels, possibly affecting calcium-sensitive signaling pathways that TECPR2 is part of, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC), which could phosphorylate proteins within pathways where TECPR2 is involved, potentially influencing its activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that activates PKA leading to phosphorylation of proteins that may interact with TECPR2, influencing its activation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium, mimicking calcium signaling and potentially affecting TECPR2 function through calcium-dependent pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within signaling networks that could involve TECPR2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, altering downstream AKT signaling which could impact TECPR2 activity if it is functionally connected to this pathway. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, indirectly altering calcium-dependent signaling pathways that may be linked to TECPR2 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1, which may impact ERK signaling. Perturbations in this pathway could indirectly influence TECPR2 activity through protein-protein interactions or phosphorylation events. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, potentially affecting signaling cascades that could modulate TECPR2 function through changes in phosphorylation patterns. | ||||||